Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Local inflammatory mediators and perianal tissue proteins refer to a broad collective of molecular entities involved in the pathophysiology of anorectal disorders such as hemorrhoids, anal fissures, and perianal Crohn's disease. This group includes pro-inflammatory cytokines like TNF-alpha, IL-1, and IL-6, which drive the inflammatory cascade and tissue degradation in the perianal environment (Source: PubMed, PMID: 31434194). It also encompasses enzymes such as cyclooxygenase (COX) and various structural proteins like collagen and elastin that maintain tissue integrity, as well as receptors involved in vascular tone and pain transmission (Source: StatPearls, Hemorrhoids). Therapeutic strategies targeting these mediators often involve topical agents like corticosteroids to suppress immune responses or local anesthetics to block sodium channels in perianal nerves (Source: PubChem). For instance, phenylephrine is used to target alpha-adrenergic receptors to induce vasoconstriction and reduce swelling in hemorrhoidal tissues. Because this term describes a heterogeneous group of proteins and pathways rather than a single molecular target, it is classified as a multi-target therapeutic category or a descriptive physiological focus. Understanding the synergy between these mediators is essential for the development of effective localized treatments for chronic perianal inflammation and pain.
Modulation of inflammatory signaling through glucocorticoid receptor activation, inhibition of voltage-gated sodium channels to block pain, activation of alpha-1 adrenergic receptors for vasoconstriction, and donation of nitric oxide to relax the internal anal sphincter.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Local inflammatory mediators and perianal tissue proteins.